All News
Diagnostic Delay in Psoriatic Arthritis: What are the Consequences?
Despite increased awareness and better diagnostic modalities at hand, early diagnosis of psoriatic arthritis (PsA) still remains a huge unmet need.
Read ArticleSecukinumab in Psoriatic Arthritis Patients with Axial Disease
Results of the MAXIMISE trial show that Secukinumab provided clinical improvement and reduction in inflammatory MRI lesions in patients with psoriatic arthritis and axial disease through week 52.
Read ArticleJanet Pope Janetbirdope ( View Tweet)
If the presence of fibromyalgia correlates with clinical outcome scores in psoriatic arthritis (PsA), how do you differentiate between fibromyalgia and PsA disease activity? @RheumNow #ACR20
Dr. Antoni Chan synovialjoints ( View Tweet)
If the synovio-entheseal complex is important in the pathogenesis of psoriatic arthritis, how do you assess the entheses in clinic? @RheumNow #ACR20
Dr. Antoni Chan synovialjoints ( View Tweet)
Dr. Antoni Chan synovialjoints ( View Tweet)
DISCOVER-2 (52 wk study) Guselkumab 100mg q4wk and q8wk for tx of PsA 1️⃣Sustained responses in: ACR20/50/70, PASI90/100, HAQ-DI, MDA/VLDA, QoL 2️⃣Improvement enthesitis/dactylitis 3️⃣No increase rate of serious infection @RheumNow #ACR20 Abs#0506 https://t.co/7MXYTucVZ9
Dr. Antoni Chan synovialjoints ( View Tweet)
Dr. Rachel Tate uptoTate ( View Tweet)
Eric Dein ejdein1 ( View Tweet)